Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Zentek Ltd. (Nasdaq: ZTEK) has received notification from Nasdaq that it is not compliant with the minimum bid price requirement, as its shares have traded below US$1.00 for 31 consecutive business days. The company has until February 23, 2026 to regain compliance by maintaining a closing bid price of at least US$1.00 for 10 consecutive business days.
If Zentek fails to meet this deadline, it may be eligible for an additional 180-day grace period if it meets other listing requirements and provides written notice to Nasdaq. The notification is not an immediate delisting notice, and the company's shares continue to trade on the Nasdaq Capital Market while management explores options to regain compliance.
Zentek Ltd. (Nasdaq: ZTEK) ha ricevuto una comunicazione da Nasdaq che segnala la non conformit脿 al requisito minimo del prezzo di offerta, poich茅 le sue azioni sono state scambiate al di sotto di US$1,00 per 31 giorni di borsa consecutivi. La societ脿 ha tempo fino al 23 febbraio 2026 per tornare conforme mantenendo un prezzo di chiusura di almeno US$1,00 per 10 giorni di borsa consecutivi.
Se Zentek non riuscisse a rispettare tale termine, potrebbe ottenere un periodo di grazia aggiuntivo di 180 giorni se soddisfa gli altri requisiti di quotazione e fornisce a Nasdaq una comunicazione scritta. La notifica non costituisce un avviso di esclusione immediata, e le azioni della societ脿 continuano a essere negoziate sul Nasdaq Capital Market mentre la direzione valuta le opzioni per recuperare la conformit脿.
Zentek Ltd. (Nasdaq: ZTEK) ha recibido una notificaci贸n de Nasdaq indicando que no cumple el requisito m铆nimo de precio de oferta, ya que sus acciones han cotizado por debajo de US$1.00 durante 31 d铆as h谩biles consecutivos. La compa帽铆a tiene hasta el 23 de febrero de 2026 para recuperar la conformidad manteniendo un precio de cierre de al menos US$1.00 durante 10 d铆as h谩biles consecutivos.
Si Zentek no cumple con este plazo, podr铆a ser elegible para un per铆odo de gracia adicional de 180 d铆as si cumple los dem谩s requisitos de cotizaci贸n y presenta una notificaci贸n por escrito a Nasdaq. La notificaci贸n no es una orden de exclusi贸n inmediata, y las acciones de la compa帽铆a contin煤an cotizando en el Nasdaq Capital Market mientras la direcci贸n estudia opciones para recuperar la conformidad.
Zentek Ltd. (Nasdaq: ZTEK)電� 鞛愳偓 欤检嫕鞚� 臧�瓴╈澊 鞐办啀 鞓侅梾鞚� 31鞚� 霃欖晥 氙疙檾 1.00雼煬 氙鸽鞙茧 瓯半灅霅橃柎 斓滌爛 鞛呾鞍臧�瓴� 鞖旉贝鞚� 於╈”頃橃 氇豁暅雼る姅 韱奠毳� Nasdaq搿滊秬韯� 氚涭晿鞀惦媹雼�. 須岇偓電� 2026雲� 2鞗� 23鞚�旯岇 膦呹皜臧� 斓滌唽 氙疙檾 1.00雼煬 鞚挫儊鞙茧 鞐办啀 10鞓侅梾鞚� 霃欖晥 鞙犾霅橃柎 攴滌爼 欷�靾橂ゼ 須岆车頃挫暭 頃╇媹雼�.
Zentek鞚� 頃措嫻 旮绊暅鞚� 歆�韨れ 氇豁暊 瓴届毎, 雼るジ 靸侅灔 鞖旉贝鞚� 於╈”頃橁碃 Nasdaq鞐� 靹滊┐ 韱奠毳� 鞝滌稖頃橂┐ 於旉皜搿� 180鞚检潣 鞙犾槇 旮瓣皠鞚� 氚涭潉 靾� 鞛堨姷雼堧嫟. 鞚� 韱奠電� 歃夓嫓 靸侅灔韽愳 韱惦炒臧� 鞎勲媹氅�, 瓴届榿歆勳澊 攴滌爼 欷�靾� 須岆车 氚╈晥鞚� 瓴�韱犿晿電� 霃欖晥 須岇偓鞚� 欤检嫕鞚� Nasdaq Capital Market鞐愳劀 瓿勳啀 瓯半灅霅╇媹雼�.
Zentek Ltd. (Nasdaq: ZTEK) a re莽u une notification de Nasdaq indiquant qu'elle ne respecte pas l'exigence minimale de cours d'ench猫re, ses actions ayant 茅t茅 n茅goci茅es en dessous de 1,00 $ US pendant 31 jours de bourse cons茅cutifs. La soci茅t茅 dispose jusqu'au 23 f茅vrier 2026 pour retrouver la conformit茅 en maintenant un cours de cl么ture d'au moins 1,00 $ US pendant 10 jours de bourse cons茅cutifs.
Si Zentek ne respecte pas ce d茅lai, elle pourrait b茅n茅ficier d'une p茅riode de gr芒ce suppl茅mentaire de 180 jours si elle satisfait aux autres exigences de cotation et adresse une notification 茅crite 脿 Nasdaq. Cette notification n'est pas un avis de radiation imm茅diat, et les actions de la soci茅t茅 continuent d'锚tre n茅goci茅es sur le Nasdaq Capital Market pendant que la direction examine les options pour r茅tablir la conformit茅.
Zentek Ltd. (Nasdaq: ZTEK) hat von der Nasdaq die Mitteilung erhalten, dass es die Mindestgebotspreis-Anforderung nicht erf眉llt, da die Aktien 31 aufeinanderfolgende Handelstage lang unter US$1,00 gehandelt wurden. Das Unternehmen hat bis zum 23. Februar 2026 Zeit, die Compliance wiederherzustellen, indem es einen Schlusskurs von mindestens US$1,00 f眉r 10 aufeinanderfolgende Handelstage aufrechterh盲lt.
Sollte Zentek diese Frist nicht einhalten, k枚nnte es einen zus盲tzlichen 180-t盲gigen Schonzeitraum erhalten, sofern andere Notierungsanforderungen erf眉llt und Nasdaq schriftlich informiert wird. Die Mitteilung stellt keine sofortige Delisting-Benachrichtigung dar, und die Aktien des Unternehmens werden weiterhin am Nasdaq Capital Market gehandelt, w盲hrend das Management Optionen zur Wiederherstellung der Compliance pr眉ft.
- Company remains eligible to trade on Nasdaq during compliance period
- Potential for additional 180-day grace period if initial deadline is not met
- Business operations remain unaffected by the notification
- Stock price has fallen below US$1.00 minimum requirement
- Risk of potential delisting from Nasdaq if compliance is not achieved
- May need to consider reverse stock split to maintain listing
Insights
Zentek faces Nasdaq delisting risk after share price fell below $1; has until February 2026 to regain compliance.
Zentek has received a Nasdaq notification regarding minimum bid price deficiency, a significant regulatory development that puts the company at risk of eventual delisting if not addressed. The company's shares have traded below the required
The company now enters a standard 180-day compliance period ending February 23, 2026, during which it must achieve a closing bid price above
This notification represents a serious challenge for Zentek, as sustained low share prices often reflect deeper market concerns about a company's financial health or growth prospects. While management has indicated they will "consider all available options" to regain compliance, the most common remedies include reverse stock splits (which mathematically increase share price but don't change fundamental valuation) or improving business performance to attract investor interest.
The notification doesn't immediately affect Zentek's listing status, but failure to address this deficiency could eventually lead to delisting, which would significantly impact liquidity, institutional investment eligibility, and overall market perception. Companies receiving such notifications frequently experience additional selling pressure as some investors avoid stocks with delisting risks.
Guelph, Ontario--(Newsfile Corp. - August 27, 2025) - Zentek Ltd. (Nasdaq: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces that on August 26, 2025, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US
The Notification Letter is only a notification of deficiency and not a notice of delisting. As such, the Notification Letter has no immediate effect on the listing or trading of the Company's Shares on the Nasdaq Capital Market under the symbol "ZTEK."
Nasdaq Listing Rules
Nasdaq Listing Rule 5550(a)(2) requires securities listed on the Nasdaq Capital Market to maintain a minimum bid price of US
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Zentek has a period of 180 calendar days, or until February 23, 2026, in which to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company's Shares must meet or exceed US
Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.
The Company's business operations are not affected by the receipt of the Notification Letter.
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
Zentek, through its wholly owned subsidiary, Triera Biosciences Ltd., has a global exclusive licence to the aptamer-based platform technology developed by McMaster University, which is being jointly developed by Zentek and McMaster for both the diagnostic and therapeutic markets.
For further information on Zentek:
[email protected]
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: [email protected]
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at .
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit
FAQ
What is the minimum stock price requirement for Zentek (ZTEK) to maintain Nasdaq listing?
When is the deadline for Zentek (ZTEK) to regain Nasdaq compliance?
What happens if Zentek (ZTEK) fails to meet the Nasdaq compliance deadline?
How can Zentek (ZTEK) regain Nasdaq compliance?
Is Zentek (ZTEK) being delisted from Nasdaq immediately?
